Rizzieri D - Search Results

1

Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.

Lanasa MC, Davis PH, Datto M, Li Z, Gockerman JP, Moore JO, DeCastro CM, Friedman DR, Diehl LF, Rehder C, Cook H, Daugherty FJ, Matta KM, Weinberg JB, Rizzieri D. Lanasa MC, et al. Among authors: rizzieri d. Leuk Lymphoma. 2012 Feb;53(2):218-24. doi: 10.3109/10428194.2011.610012. Epub 2011 Sep 23. Leuk Lymphoma. 2012. PMID: 21827374

2

Thrombocytosis associated with low-molecular-weight heparin.

Rizzieri DA, Wong WM, Gockerman JP. Rizzieri DA, et al. Ann Intern Med. 1996 Jul 15;125(2):157. doi: 10.7326/0003-4819-125-2-199607150-00031. Ann Intern Med. 1996. PMID: 8678382 No abstract available.

3

Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant.

Laughlin MJ, McGaughey DS, Crews JR, Chao NJ, Rizzieri D, Ross M, Gockerman J, Cirrincione C, Berry D, Mills L, Defusco P, LeGrand S, Peters WP, Vredenburgh JJ. Laughlin MJ, et al. Among authors: rizzieri d. J Clin Oncol. 1998 Mar;16(3):1008-12. doi: 10.1200/JCO.1998.16.3.1008. J Clin Oncol. 1998. PMID: 9508184

4

Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia.

Laughlin MJ, Rizzieri DA, Smith CA, Moore JO, Lilly S, McGaughey D, Martin P, Carrier C, Stevens CE, Rubinstein P, Buckley R, Kurtzberg J. Laughlin MJ, et al. Among authors: rizzieri da. Leuk Res. 1998 Mar;22(3):215-9. doi: 10.1016/s0145-2126(97)00171-9. Leuk Res. 1998. PMID: 9619913 No abstract available.

5

Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma.

McCune SL, Gockerman JP, Rizzieri DA. McCune SL, et al. Among authors: rizzieri da. JAMA. 2001 Sep 12;286(10):1149-52. doi: 10.1001/jama.286.10.1149. JAMA. 2001. PMID: 11559240 Review. No abstract available.

6

Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen.

Rizzieri DA, Long GD, Vredenburgh JJ, Gasparetto C, Morris A, Stenzel TT, Davis P, Chao NJ. Rizzieri DA, et al. Blood. 2001 Dec 1;98(12):3486-8. doi: 10.1182/blood.v98.12.3486. Blood. 2001. PMID: 11719394 Free article.

7

Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia.

Rizzieri DA, Bass AJ, Rosner GL, Gockerman JP, DeCastro CM, Petros WP, Adams DJ, Laughlin MJ, Davis P, Foster T, Jacobson R, Hurwitz H, Moore JO. Rizzieri DA, et al. J Clin Oncol. 2002 Feb 1;20(3):674-9. doi: 10.1200/JCO.2002.20.3.674. J Clin Oncol. 2002. PMID: 11821447 Clinical Trial.

8

CD52 expression in mantle cell lymphoma.

Bass AJ, Gong J, Nelson R, Rizzieri DA. Bass AJ, et al. Leuk Lymphoma. 2002 Feb;43(2):339-42. doi: 10.1080/10428190290006125. Leuk Lymphoma. 2002. PMID: 11999566

9

Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma.

Bass AJ, Gockerman JP, Hammett E, DeCastro CM, Adams DJ, Rosner GL, Payne N, Davis P, Foster T, Moore JO, Rizzieri DA. Bass AJ, et al. J Clin Oncol. 2002 Jul 1;20(13):2995-3000. doi: 10.1200/JCO.2002.08.166. J Clin Oncol. 2002. PMID: 12089230 Clinical Trial.

10

Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia.

McCune SL, Gockerman JP, Moore JO, Decastro CM, Bass AJ, Chao NJ, Long GD, Vredenburgh JJ, Gasparetto C, Adams D, Payne N, Rizzieri DA. McCune SL, et al. Among authors: rizzieri da. Leuk Lymphoma. 2002 May;43(5):1007-11. doi: 10.1080/10428190290021597. Leuk Lymphoma. 2002. PMID: 12148879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page